CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
65,162,167
Share change
-348,774
Total reported value
$345,106,769
Put/Call ratio
305%
Price per share
$5.30
Number of holders
138
Value change
-$2,224,745
Number of buys
58
Number of sells
70

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2021

As of 30 Sep 2021, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,162,167 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, LSV ASSET MANAGEMENT, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, PRUDENTIAL FINANCIAL INC, and ACADIAN ASSET MANAGEMENT LLC. This page lists 139 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
137
Q3 2021 holders
138
Holder diff
1
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.